Hexarelin
From PeptideSciences101, the open peptide reference. · Last updated: October 7, 2025
This article is a stub. A peer-reviewed deep-dive is in preparation. Help contribute to expand it.
…
Overview
Powerful growth hormone secretagogue with additional cardiovascular benefits.
Reported benefits
Strong GH release, cardioprotective effects, potential cognitive benefits
Protocols & dosing
Typical dosage: 100 mcg (daily).
Detailed dosing protocols have not yet been catalogued.
FDA & legal status
Hexarelin is not currently FDA-approved for any indication. It is generally classified as a research compound. Regulatory status varies by country.
| Country | Status |
|---|---|
| United States | Research use only |
| United Kingdom | Prescription-only / not licensed |
| Canada | Prescription-only / Schedule F if licensed |
| Australia | TGA-scheduled |
Vendor information
PeptideSciences101 does not endorse vendors. For transparency metrics and third-party testing notes, see the vendor directory.
Side effects & safety
Reported side effects: Desensitization with continuous use, cortisol elevation possible
References
No external sources have been catalogued for this article yet.
Related peptides
- ACE-031 — Myostatin inhibitor
- CJC-1295 — Growth hormone, muscle mass, fat loss
- Epithalon + Follistatin Stack — Anti-aging performance combo
- GHRP-4 — Fourth generation GHRP
- HGH Fragment 176-191 — Fat loss without GH effects
- Ipamorelin — GH secretagogue, anti-aging
Categories: Performance & Growth